New insights into the prevention and treatment of familial breast cancer

Research output: Contribution to journalReview article

Abstract

Individuals who inherit a deleterious mutation in BRCA1 or BRCA2 are at very high risk for breast cancer but there are several strategies available for successfully managing this risk. Breast cancers that develop in the context of germline BRCA gene mutation present challenges for management but also opportunities. DNA damaging agents, like cisplatin, and the new class of drugs called PARP inhibitors exploit the underlying defect in DNA damage repair to great effect.

Original languageEnglish (US)
Pages (from-to)294-298
Number of pages5
JournalJournal of Surgical Oncology
Volume103
Issue number4
DOIs
StatePublished - Mar 15 2011
Externally publishedYes

Keywords

  • BRCA1
  • BRCA2
  • Chemoprevention
  • Cisplatin
  • Mastectomy
  • Oophorectomy
  • PARP inhibitors

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'New insights into the prevention and treatment of familial breast cancer'. Together they form a unique fingerprint.

  • Cite this